CGB3002
/ ChainGen Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 09, 2026
SAD Study of CGB3002 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=46 | Recruiting | Sponsor: ChainGen Biopharma Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1